BIOVENTUS INC - A (BVS) Stock News
NASDAQ:BVS - Nasdaq - US09075A1088 - Common Stock - Currency: USD
BVS Latest News, Press Relases and Analysis
Bioventus to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Bioventus Completes Divestiture of its Advanced Rehabilitation Business to Accelmed Partners
DURHAM, N.C., Jan. 02, 2025 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active...
Bioventus Completes Divestiture of its Advanced Rehabilitation Business to Accelmed Partners
Solventum Stock Earns 81 RS Rating
Solventum stock saw a positive improvement to its Relative Strength Rating on Tuesday, with an upgrade from 78 to 81.
Bioventus Reports Third Quarter Financial Results
Q3 Revenue Advanced by 15.0%, Fourth Straight Quarter of Double Digit Organic* GrowthQ3 Gross Margin Expanded 200 bpsQ3 Cash from Operations of $10.3...
Bioventus Reports Third Quarter Financial Results
Bioventus to Report Third Quarter of Fiscal Year 2024 Financial Results on November 5, 2024
DURHAM, N.C., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active...
BVS Stock Earnings: Bioventus Beats EPS, Beats Revenue for Q2 2024
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Bioventus (NASDAQ:BVS) just reported results for the second quarter of 2024.Bio...
BVS Stock Earnings: Bioventus Beats EPS, Beats Revenue for Q2 2024
BVS stock results show that Bioventus beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
3 Stocks Under $10 With Mammoth Growth Prospects
Learn more about the growth stocks under $10 with progressive fundamentals in the healthcare and technology sectors.
Bioventus to Report Third Quarter of Fiscal Year 2024 Financial Results on November 5, 2024
Bioventus Announces Divestiture of its Advanced Rehabilitation Business to Accelmed Partners
DURHAM, N.C., Oct. 01, 2024 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active...
Bioventus Announces Divestiture of its Advanced Rehabilitation Business to Accelmed Partners
BVS Stock Earnings: Bioventus Beats EPS, Beats Revenue for Q1 2024
BVS stock results show that Bioventus beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Bioventus to Present at the Canaccord Genuity 44th Annual Global Growth Conference
DURHAM, N.C., Aug. 07, 2024 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that...
Bioventus to Present at the Canaccord Genuity 44th Annual Global Growth Conference
Bioventus Reports Second Quarter Financial Results
Q2 Revenue Advanced by 10.3%, Organic Growth* by 13.9%Q2 Gross Margin Expanded 350 bps and Adjusted Gross Margin* 180 bpsCash from Operations of $15.2...
Bioventus Reports Second Quarter Financial Results
Bioventus to Report Second Quarter of Fiscal Year 2024 Financial Results on August 6, 2024
DURHAM, N.C., July 30, 2024 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active...
Bioventus to Report Second Quarter of Fiscal Year 2024 Financial Results on August 6, 2024
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Pre-market stock movers are a hot topic this morning and we've got traders covered with all of the news behind these movements on Thursday!
Bioventus Reports First Quarter Financial Results
Raises Full-Year 2024 Financial Guidance Reflecting Enhanced Revenue Growth and Strong Execution of Strategic PrioritiesAccelerated First Quarter Revenue...
Bioventus Reports First Quarter Financial Results
Bioventus to Report First Quarter of Fiscal Year 2024 Financial Results on May 7, 2024
DURHAM, N.C., April 29, 2024 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active...